Author:
Maghbooli Zhila,Shirvani Arash,Moghadasi Abdorreza Naser,Varzandi Tarlan,Hamtaei Ghashti Sara,Sahraian Mohammad Ali
Reference35 articles.
1. Redefining acute relapses in multiple sclerosis: implications for phase 3 clinical trials and treatment algorithms;Avasarala;Innov. Clin. Neurosci.,2017
2. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men;Barger-Lux;Osteoporos. Int.,1998
3. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls;Bhargava;Mult. Scler.,2016
4. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation;Biancuzzo;J. Clin. Endocrinol. Metab.,2013
5. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity;Bischoff-Ferrari;J. Bone. Miner. Res.,2012